These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 18836586)
1. Targeting ribosomal S-6 kinase for the prevention and treatment of liver injury and liver fibrosis. Buck M Drug News Perspect; 2008; 21(6):301-6. PubMed ID: 18836586 [TBL] [Abstract][Full Text] [Related]
2. A ribosomal S-6 kinase-mediated signal to C/EBP-beta is critical for the development of liver fibrosis. Buck M; Chojkier M PLoS One; 2007 Dec; 2(12):e1372. PubMed ID: 18159255 [TBL] [Abstract][Full Text] [Related]
3. C/EBPbeta associates with caspase 8 complex proteins and modulates apoptosis in hepatic stellate cells. Buck M; Chojkier M J Clin Gastroenterol; 2007; 41 Suppl 3():S295-9. PubMed ID: 17975479 [TBL] [Abstract][Full Text] [Related]
4. Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP. Schattenberg JM; Nagel M; Kim YO; Kohl T; Wörns MA; Zimmermann T; Schad A; Longerich T; Schuppan D; He YW; Galle PR; Schuchmann M Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(4):G498-506. PubMed ID: 22700824 [TBL] [Abstract][Full Text] [Related]
5. C/EBPβ-Thr217 phosphorylation signaling contributes to the development of lung injury and fibrosis in mice. Buck M; Chojkier M PLoS One; 2011; 6(10):e25497. PubMed ID: 21998664 [TBL] [Abstract][Full Text] [Related]
6. Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo. Du G; Wang J; Zhang T; Ding Q; Jia X; Zhao X; Dong J; Yang X; Lu S; Zhang C; Liu Z; Zeng Z; Safadi R; Qi R; Zhao X; Hong Z; Lu Y Cell Death Dis; 2020 Feb; 11(2):118. PubMed ID: 32051399 [TBL] [Abstract][Full Text] [Related]
7. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716 [TBL] [Abstract][Full Text] [Related]
8. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors. Liu Y; Saiyan S; Men TY; Gao HY; Wen C; Liu Y; Zhou X; Wu CT; Wang LS; Cui CP J Pathol; 2013 Aug; 230(4):365-76. PubMed ID: 23839903 [TBL] [Abstract][Full Text] [Related]
9. C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Buck M; Poli V; Hunter T; Chojkier M Mol Cell; 2001 Oct; 8(4):807-16. PubMed ID: 11684016 [TBL] [Abstract][Full Text] [Related]
10. Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis. Qiang H; Lin Y; Zhang X; Zeng X; Shi J; Chen YX; Yang MF; Han ZG; Xie WF Liver Int; 2006 Nov; 26(9):1126-37. PubMed ID: 17032414 [TBL] [Abstract][Full Text] [Related]
11. CCAAT-enhancer-binding protein beta activation of MMP-1 gene expression in SW1353 cells: independent roles of extracellular signal-regulated and p90/ribosomal S6 kinases. Petrella BL; Armstrong DA; Vincenti MP J Cell Physiol; 2011 Dec; 226(12):3349-54. PubMed ID: 21344389 [TBL] [Abstract][Full Text] [Related]
12. Adiponectin-derived active peptide ADP355 exerts anti-inflammatory and anti-fibrotic activities in thioacetamide-induced liver injury. Wang H; Zhang H; Zhang Z; Huang B; Cheng X; Wang D; la Gahu Z; Xue Z; Da Y; Li D; Yao Z; Gao F; Xu A; Zhang R Sci Rep; 2016 Jan; 6():19445. PubMed ID: 26777428 [TBL] [Abstract][Full Text] [Related]
13. RSK-mediated phosphorylation in the C/EBP{beta} leucine zipper regulates DNA binding, dimerization, and growth arrest activity. Lee S; Shuman JD; Guszczynski T; Sakchaisri K; Sebastian T; Copeland TD; Miller M; Cohen MS; Taunton J; Smart RC; Xiao Z; Yu LR; Veenstra TD; Johnson PF Mol Cell Biol; 2010 Jun; 30(11):2621-35. PubMed ID: 20351173 [TBL] [Abstract][Full Text] [Related]
14. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Kim WH; Matsumoto K; Bessho K; Nakamura T Am J Pathol; 2005 Apr; 166(4):1017-28. PubMed ID: 15793283 [TBL] [Abstract][Full Text] [Related]
15. Tetramethylpyrazine induces G0/G1 cell cycle arrest and stimulates mitochondrial-mediated and caspase-dependent apoptosis through modulating ERK/p53 signaling in hepatic stellate cells in vitro. Zhang F; Kong DS; Zhang ZL; Lei N; Zhu XJ; Zhang XP; Chen L; Lu Y; Zheng SZ Apoptosis; 2013 Feb; 18(2):135-49. PubMed ID: 23247439 [TBL] [Abstract][Full Text] [Related]
16. Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis. Yang JJ; Tao H; Huang C; Li J Food Chem Toxicol; 2013 Sep; 59():421-7. PubMed ID: 23793039 [TBL] [Abstract][Full Text] [Related]
17. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126 [TBL] [Abstract][Full Text] [Related]
18. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation. Bárcena C; Stefanovic M; Tutusaus A; Joannas L; Menéndez A; García-Ruiz C; Sancho-Bru P; Marí M; Caballeria J; Rothlin CV; Fernández-Checa JC; de Frutos PG; Morales A J Hepatol; 2015 Sep; 63(3):670-8. PubMed ID: 25908269 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway. Dai W; Zhao J; Tang N; Zeng X; Wu K; Ye C; Shi J; Lu C; Ning B; Zhang J; Lin Y Liver Int; 2015 Apr; 35(4):1234-43. PubMed ID: 25142507 [TBL] [Abstract][Full Text] [Related]
20. Hydroxysafflor yellow A induces apoptosis in activated hepatic stellate cells through ERK1/2 pathway in vitro. Li CC; Yang CZ; Li XM; Zhao XM; Zou Y; Fan L; Zhou L; Liu JC; Niu YC Eur J Pharm Sci; 2012 Aug; 46(5):397-404. PubMed ID: 22449726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]